Thu, 16 May 2013
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis (audio)
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews early efforts in molecularly-defined staging of patients with early stage non-small cell lung cancer (NSCLC).
Direct download: GRACEcast-151_Lung-Audio_Early_Steps_in_Molecularly_Defined_Prognosis.mp3
Category:Lung-Cancer-Audio -- posted at: 6:17pm PDT